Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaiho

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
International Journal of Cancer|August 14, 1999
Suppression of solid tumor growth by a monoclonal antibody against tumor vasculature in rats: involvement of intravascular thrombosis and fibrinogenesisI Ohizumi, K Taniguchi, H Saito, et al.
Biochemical and Biophysical Research Communications|July 18, 1997
Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in ratsI Ohizumi, S Tsunoda, K Taniguchi, et al.
Japanese Journal of Cancer Research : Gann|December 21, 2000
Effective cancer targeting using an anti-tumor tissue vascular endothelium-specific monoclonal antibody (TES-23)Y Wakai, J Matsui, K Koizumi, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
International Journal of Cancer|August 14, 1999
Suppression of solid tumor growth by a monoclonal antibody against tumor vasculature in rats: involvement of intravascular thrombosis and fibrinogenesisI Ohizumi, K Taniguchi, H Saito, et al.
Biochemical and Biophysical Research Communications|July 18, 1997
Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in ratsI Ohizumi, S Tsunoda, K Taniguchi, et al.
Japanese Journal of Cancer Research : Gann|December 21, 2000
Effective cancer targeting using an anti-tumor tissue vascular endothelium-specific monoclonal antibody (TES-23)Y Wakai, J Matsui, K Koizumi, et al.
Pageof 2